Serum creatine kinase: A marker for muscle damage in sickle cell painful crisis

Annals of Saudi Medicine

Volumn 19, Issue 3, 1999, Pages 264-266

  Agarwal, M M ^a   Ankra Badu, George A ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ARTICLE; BLOOD CHEMISTRY; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; EXERCISE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE INJURY; MUSCLE ISCHEMIA; PATHOGENESIS; PRIORITY JOURNAL; SAUDI ARABIA; SICKLE CELL CRISIS;

EID: 0033394252     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1999.264     Document Type: Article

References (24)

1. Ebashi S, Toyokura T, Momoi H, Sugita H. High creatine phosphokinase activity of sera of progressive muscular dystrophy patients. Bioch J Tokyo 1959;46:103.
2. Lott JA, Wolf PL. Creatine kinase. In: Lott JA, Wolf PL, editors. Clinical enzymology: a case-oriented approach. New York: Field, Rich and Associates, 1986:213-44.
3. Brozovic M, Anionwu E. Sickle cell disease in Britain. J Clin Pathol 1984;37:1321-6.
4. Diggs LW. Sickle cell crisis. Am J Clin Path 1965;44:1-19.
5. Serjeant GR. Sickle cell disease. Oxford: Oxford University Press, 1985:196.
6. Devereux S, Knowles SM. Rhabdomyolysis and acute renal failure in sickle cell anemia. BMJ 1985;290:1707.
7. Kelly CJ, Singer I. Acute renal failure in sickle cell disease. Am J Kidney Dis 1986;8:46-50.
8. Hunt BJ, Korash P, Eaton S, Brozovic M. Creatine kinase activity in sickle cell disease. J Clin Pathol 1989;42:712-5.
9. Perrine RP, John P, Pembrey M, Perrine S. Sickle cell disease in Saudi Arabia in early childhood. Arch Dis Child 1981;56:187-92.
10. Rosalki SB. Enzyme assays in diseases of the heart and skeletal muscle. J Clin Pathol 1970;24:60-70.
11. Meltezer HY. Factors affecting creatine phosphokinase levels in the general population. The role of race, activity and age. Clin Chem Acta 1971;33:165-72.
12. Black HR, Quallich BA, Gareleck CB. Racial differences in creatine kinase and isomerase activity with exercise duration. Eur J Appl Physiol 1978;39:191-201.
13. Evans WJ, Meredith CN, Cannon JG. Metabolic changes following eccentric exercise in trained and untrained men. J Appl Physiol 1986;61:1864-7.
14. Sidell FR, Culner DL, Kaminiskis A. Serum creatine phosphokinase activity after intramuscular injection. JAMA 1974;229:1894-6.
15. Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 1980;26:1241-50.
16. Tzevtanova E. Serum creatine kinase isoenzyme in progressive muscular dystrophy. Enzyme 1978;23:238-45.
17. Lott JA, Landensman PN. The enzymology of skeletal muscle disorders. Crit Rev Clin Lab Sci 1984;20:153-90.
18. Jenkins DJ. An investigation into creatine kinase and other disorders in thyroid disorders. Clin Chem Acta 1978;85:197-204.
19. Pfeiffer FE, Hamburger HA, Yanagihara T. Serum creatine kinase B concentrations in acute cerebrovascular diseases. Arch Neurol 1984;41:1175-8.
20. McMahon LEC, Mark EJ. Case records of the Massachusetts General Hospital. A 22-year-old man with sickle cell crisis and sudden death. N Engl J Med 1997;337:1293-301.
21. Nduka N, Kazem Y, Saleh B. Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease. J Clin Pathol 1995;48:648-51.
22. Better OS, Stein JH. Current concepts: early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990;332;825-9.
23. Alavi A, Bond JP, Kuhl DE, Creech RM. Scan detection of bone marrow infarcts in sickle cell disorders. J Nucl Med 1974;15:1003-7.
24. Lutzker LG, Alavi A. Bone marrow imaging in sickle cell disease: diagnosis of infarction. Semin Nucl Med 1976;6:83-93.